PET imaging of 86Y-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: Comparison between 86Y and 111In radiolabels

Journal of Nuclear Medicine

Volumn 42, Issue 8, 2001, Pages 1281-1287

  Lovqvist A ^a   Humm, J L ^a   Sheikh, A ^a   Finn, R D ^a   Koziorowski, J ^a   Ruan, S ^a   Pentlow, K S ^a   Jungbluth, A ^a   Welt, S ^a   Lee, F T ^a   Brechbiel, M W ^a   Larson, S M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

3S193 antibody; 86Y; Lewis Y; PET imaging; Radioimmunotherapy

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HU3S193; MONOCLONAL ANTIBODY IN 111; MONOCLONAL ANTIBODY Y 86; UNCLASSIFIED DRUG; YTTRIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CARCINOMA; DRUG DISTRIBUTION; HUMAN; HUMAN CELL; ISOTOPE LABELING; MOUSE; NONHUMAN; NUDE MOUSE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; AUTORADIOGRAPHY; COLONIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INDIUM RADIOISOTOPES; MICE; MICE, NUDE; MODELS, BIOLOGICAL; NEOPLASM TRANSPLANTATION; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; YTTRIUM RADIOISOTOPES;

EID: 0034908279     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. A new look at radionuclides therapy in metastatic disease of bone
2. Current status of systemic intravenous radiopharmaceuticals for the treatment of painful metastatic bone disease
3. Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography
4. Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody
5. Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma
6. Yttrium-90/indium-111-DOTA-peptide-chimeric L6: Pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer
7. Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49
8. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients
9. Quantitative Bremsstrahlung imaging of yttrium-90 using a Wiener filter
10. Planar gamma camera imaging and quantitation of yttrium-90 Bremsstrahlung
11. Quantitative Bremsstrahlung single photon emission computed tomographic imaging: Use for volume, activity, and absorbed dose calculations
12. Body contour determination and validation for Bremsstrahlung SPECT imaging
13. Yttrium-90 biodistribution by yttrium-87 imaging: A theoretical feasibility analysis
14. Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 radiotherapeutics
15. y determinants
16. Construction, production and characterization of humanized anti-Lewis Y monoclonal antibody 3S193 for targeted immunotherapy of solid tumors
17. Low energy cyclotron production and separation of yttrium-86 for evaluation of monoclonal antibody pharmacokinetics and dosimetry
18. In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice
19. y humanized 3S193 (hu3S193) radioimmunotherapy in a breast cancer model: Enhanced activity when combined with taxol chemotherapy
20. Quantitative imaging of yttrium-86 with PET: A potential problem and a proposed correction